This post was originally published on this site
https://i-invdn-com.investing.com/news/LYNXMPEBBR0PM_M.jpg
The Hang Seng equity index has fallen about 13% this year and the MSCI China index has lost about 20% against a 12% rise in world stocks.
On Dec. 2, the Hang Seng was at 23,714, MSCI China at 86.733 and the blue-chip CSI300 index at 4,854.6.
Here is a summary of some forecasts for Chinese assets at the end of 2022:
INVESTMENT HANG SENG MSCI CHINA CSI300 USD/CNY
HOUSE TARGET TARGET TARGET
Goldman Sachs (NYSE:GS) 105 5,500 6.2
(12-month
f’cast)
Morgan Stanley (NYSE:MS) 25,000 95 5,250 6.4
Barclays (LON:BARC) 6.5
HSBC 28,030
Standard 6.5
Chartered
KEY COMMENTS:
*GOLDMAN SACHS
“We believe Chinese stocks will have a better year in 2022 as the market recovers from a major correction and transitions into a ‘hope’ phase, where P/E expansion typically trumps weak fundamental growth and drives strong equity gains.”
*MORGAN STANLEY
“MSCI China has had its worst ever relative performance drawdown vs. broad emerging markets in 2021…despite such a record underperforming year, we still see some lingering risks skewed towards higher volatility or more downside in the near term. This makes us believe that now is not yet the right time to go bullish at a broad index level.”
*HSBC
“We think markets have been overzealous in selling Chinese stock… most funds are underweight and as the focus returns to growth in China, we think this market will roar back.”
** Credit Suisse (SIX:CSGN)
“Amid the expected relatively friendly policy environment and reasonable liquidity, we remain constructive on China A-share markets, despite the possible negative impact from the expected Fed’s tightening cycle. The Hong Kong stock market is likely to have a bigger impact from overseas macro and market volatilities, while we expect sector rotation could tilt back towards growth.”
